Cytokinetics Inc CYTK
1,000 filings, 14 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 95 events
- Nov 9, 2026 Planned sale B LYNNE PARSHALL (Director) gave notice of a planned sale of 5,000 shares worth about $268KForm 144, approximate sale date Nov 9, 2026, under a 10b5-1 plan adopted Aug 10, 2026
- Nov 4, 2026 Planned sale B. Lynne Parshall (member of our board of directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 20,000 shares, runs to Sep 3, 2027
- Nov 4, 2026 Planned sale Fady I. Malik (Executive Vice President, Research and Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 144,075 shares, runs to Dec 21, 2027
- Nov 4, 2026 Planned sale John T. Henderson (Chairman of our board of directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 28,064 shares, runs to May 18, 2027
- Nov 4, 2026 Planned sale Andrew Callos (Executive Vice President, Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 67,414 shares, runs to Dec 1, 2027
- Nov 4, 2026 Planned sale Robert A. Harrington (member of our board of directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 3,425 shares, runs to Jul 31, 2027
- Nov 4, 2026 Planned sale Sung H. Lee (Executive Vice President, Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 37,991 shares, runs to Dec 31, 2027
- Nov 4, 2026 Planned sale Robert I. Blum (President and Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 240,000 shares, runs to Nov 30, 2027
- Nov 4, 2026 8-K Quarterly results8-K item 2.02
- Nov 4, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 20, 2026 Planned sale FADY MALIK (Officer) gave notice of a planned sale of 16,386 shares worth about $1.0MForm 144, approximate sale date Oct 20, 2026, under a 10b5-1 plan adopted Dec 23, 2025
- Oct 13, 2026 Planned sale ROBERT BLUM (Director, Officer) gave notice of a planned sale of 22,500 shares worth about $1.4MForm 144, approximate sale date Oct 12, 2026, under a 10b5-1 plan adopted Dec 24, 2025
- Sep 15, 2026 Planned sale Robert I. Blum (President, CEO, Director) gave notice of a planned sale of 97,926 shares worth about $7.1MForm 144, approximate sale date Sep 15, 2026
- Sep 11, 2026 Planned sale ROBERT LANDRY (Director) gave notice of a planned sale of 2,000 shares worth about $147KForm 144, approximate sale date Sep 11, 2026, under a 10b5-1 plan adopted Jun 12, 2026
- Sep 1, 2026 Planned sale B LYNNE PARSHALL (Director) gave notice of a planned sale of 5,000 shares worth about $355KForm 144, approximate sale date Sep 1, 2026, under a 10b5-1 plan adopted Aug 20, 2025
- Aug 28, 2026 8-K Other events8-K item 8.01
- Aug 13, 2026 8-K Other events8-K item 8.01
- Aug 6, 2026 Planned sale Wendell Wierenga adopted a 10b5-1 trading planreported in the 10-Q, up to 45,714 shares, runs to May 16, 2028
- Aug 6, 2026 Planned sale Robert E. Landry adopted a 10b5-1 trading planreported in the 10-Q, up to 2,000 shares, runs to Jun 4, 2027
- Aug 6, 2026 8-K Quarterly results8-K item 2.02
- Aug 6, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 30, 2026 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 24,000 shares worth about $1.9MForm 144, approximate sale date Jul 30, 2026, under a 10b5-1 plan adopted Sep 5, 2025
- Jul 7, 2026 Planned sale FADY MALIK (Officer) gave notice of a planned sale of 24,500 shares worth about $2.1MForm 144, approximate sale date Jul 7, 2026, under a 10b5-1 plan adopted Dec 23, 2025
- Jul 1, 2026 Planned sale ROBERT BLUM (Director, Officer) gave notice of a planned sale of 52,500 shares worth about $4.5MForm 144, approximate sale date Jul 1, 2026, under a 10b5-1 plan adopted Dec 24, 2025
- Jun 29, 2026 Planned sale Sung Lee (Officer) gave notice of a planned sale of 9,503 shares worth about $781KForm 144, approximate sale date Jun 29, 2026, under a 10b5-1 plan adopted Dec 23, 2025
- Jun 26, 2026 Planned sale Sung Lee (Officer) gave notice of a planned sale of 6,695 shares worth about $541KForm 144, approximate sale date Jun 26, 2026, under a 10b5-1 plan adopted Dec 23, 2025
- Jun 24, 2026 Planned sale Sung Lee (Officer) gave notice of a planned sale of 38,730 shares worth about $3.1MForm 144, approximate sale date Jun 24, 2026, under a 10b5-1 plan adopted Dec 23, 2025
- Jun 1, 2026 Planned sale EDWARD KAYE (Director) gave notice of a planned sale of 2,933 shares worth about $225KForm 144, approximate sale date Jun 1, 2026, under a 10b5-1 plan adopted Mar 2, 2026
- May 27, 2026 8-K Shareholder vote results8-K item 5.07
- May 8, 2026 8-K Other events8-K item 8.01
- May 7, 2026 Offering Sale of 9.9M new shares424B5 · We are offering 9,859,155 shares of our common stock pursuant to this prospectus supplement and the accompanying prospectus.
- May 5, 2026 Planned sale SUNG LEE (Officer) gave notice of a planned sale of 23,906 shares worth about $1.6MForm 144, approximate sale date May 5, 2026, under a 10b5-1 plan adopted Dec 23, 2025
- May 5, 2026 Planned sale JOHN HENDERSON (Director) gave notice of a planned sale of 20,000 shares worth about $1.3MForm 144, approximate sale date May 5, 2026, under a 10b5-1 plan adopted Sep 2, 2025
- May 5, 2026 Planned sale WENDELL WIERENGA (Director) gave notice of a planned sale of 4,032 shares worth about $266KForm 144, approximate sale date May 5, 2026, under a 10b5-1 plan adopted May 14, 2025
- May 5, 2026 Planned sale Edward M. Kaye (M.D) adopted a 10b5-1 trading planreported in the 10-Q, up to 29,347 shares, runs to Feb 28, 2027
- May 5, 2026 8-K Quarterly results8-K item 2.02
- May 5, 2026 8-K Other events8-K item 8.01
- May 5, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 15, 2026 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 79,639 shares worth about $5.3MForm 144, approximate sale date Apr 15, 2026, under a 10b5-1 plan adopted Sep 5, 2025
- Apr 7, 2026 Planned sale FADY MALIK (Officer) gave notice of a planned sale of 22,000 shares worth about $1.4MForm 144, approximate sale date Apr 7, 2026, under a 10b5-1 plan adopted Dec 23, 2025
- Apr 1, 2026 Planned sale ROBERT BLUM (Director, Officer) gave notice of a planned sale of 45,000 shares worth about $3.0MForm 144, approximate sale date Apr 1, 2026, under a 10b5-1 plan adopted Dec 24, 2025
- Mar 31, 2026 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 3,639 shares worth about $229KForm 144, approximate sale date Mar 31, 2026, under a 10b5-1 plan adopted Sep 5, 2025
- Mar 18, 2026 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 1,930 shares worth about $120KForm 144, approximate sale date Mar 18, 2026, under a 10b5-1 plan adopted Sep 5, 2025
- Mar 16, 2026 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 1,709 shares worth about $103KForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted Sep 5, 2025
- Mar 2, 2026 Planned sale B LYNNE PARSHALL (Director) gave notice of a planned sale of 10,000 shares worth about $622KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Aug 20, 2025
- Feb 26, 2026 Planned sale Fady Malik (Executive Vice President, Research & Development) adopted a 10b5-1 trading planreported in the 10-K, up to 62,886 shares, runs to Dec 18, 2026
- Feb 26, 2026 Planned sale Sung Lee (Executive Vice President & Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 70,107 shares, runs to Dec 31, 2026
- Feb 26, 2026 Planned sale Robert I. Blum (President & Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 120,000 shares, runs to Nov 30, 2026
- Feb 26, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 24, 2026 8-K Quarterly results8-K item 2.02
- Feb 17, 2026 8-K Other events8-K item 8.01
- Jan 2, 2026 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 59,570 shares worth about $3.8MForm 144, approximate sale date Jan 2, 2026, under a 10b5-1 plan adopted Sep 5, 2025
- Dec 29, 2025 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 1,809 shares worth about $114KForm 144, approximate sale date Dec 29, 2025, under a 10b5-1 plan adopted Sep 5, 2025
- Dec 22, 2025 Planned sale WENDELL WIERENGA (Director) gave notice of a planned sale of 20,000 shares worth about $1.3MForm 144, approximate sale date Dec 22, 2025, under a 10b5-1 plan adopted May 14, 2025
- Dec 19, 2025 8-K Other events8-K item 8.01
- Dec 12, 2025 8-K Other events8-K item 8.01
- Dec 5, 2025 Planned sale ANDREW CALLOS (Officer) gave notice of a planned sale of 53,528 shares worth about $3.6MForm 144, approximate sale date Dec 5, 2025, under a 10b5-1 plan adopted Sep 5, 2025
- Dec 2, 2025 Planned sale JOHN T HENDERSON (Director) gave notice of a planned sale of 8,750 shares worth about $578KForm 144, approximate sale date Dec 2, 2025, under a 10b5-1 plan adopted Sep 2, 2025
- Dec 1, 2025 Planned sale EDWARD KAYE (Director) gave notice of a planned sale of 28,064 shares worth about $1.9MForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Mar 6, 2025
- Nov 19, 2025 Planned sale B LYNNE PARSHALL (Director) gave notice of a planned sale of 5,000 shares worth about $331KForm 144, approximate sale date Nov 19, 2025, under a 10b5-1 plan adopted Aug 20, 2025
- Nov 14, 2025 8-K Director or officer change8-K item 5.02
- Nov 5, 2025 Planned sale B. Lynne Parshall adopted a 10b5-1 trading planreported in the 10-Q, up to 20,000 shares, runs to Sep 3, 2026
- Nov 5, 2025 Planned sale John T. Henderson adopted a 10b5-1 trading planreported in the 10-Q, up to 28,750 shares, runs to May 18, 2026
- Nov 5, 2025 Planned sale Andrew Callos adopted a 10b5-1 trading planreported in the 10-Q, up to 219,833 shares, runs to Dec 1, 2026
- Nov 5, 2025 8-K Quarterly results8-K item 2.02
- Nov 5, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Sep 22, 2025 8-K Material agreement signed, New debt or obligation, Unregistered share sale, Other events8-K items 1.01, 2.03, 3.02, 8.01
- Sep 16, 2025 8-K Other events8-K item 8.01
- Sep 8, 2025 8-K Other events (amended)8-K item 8.01
- Sep 3, 2025 8-K Other events8-K item 8.01
- Sep 2, 2025 8-K Other events8-K item 8.01
- Aug 20, 2025 8-K Director or officer change8-K item 5.02
- Aug 13, 2025 SEC letter SEC asked 1 question about Form 10-K for the fiscal year ended December 31, 2024letters Jul 29, 2025 to Aug 13, 2025 · Results discussion (MD&A)
- Aug 7, 2025 Planned sale Robert A. Harrington adopted a 10b5-1 trading planreported in the 10-Q, up to 4,300 shares, runs to Dec 5, 2025
- Aug 7, 2025 Planned sale Wendell Wierenga adopted a 10b5-1 trading planreported in the 10-Q, up to 28,407 shares, runs to Jan 1, 2027
- Aug 7, 2025 8-K Quarterly results8-K item 2.02
- Aug 7, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- May 16, 2025 8-K Shareholder vote results8-K item 5.07
- May 6, 2025 Planned sale Edward M. Kaye (M.D) adopted a 10b5-1 trading planreported in the 10-Q, up to 23,844 shares, runs to Jul 1, 2026
- May 6, 2025 8-K Quarterly results8-K item 2.02
- May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- May 1, 2025 8-K Other events8-K item 8.01
- Mar 10, 2025 8-K Regulation FD disclosure8-K item 7.01
- Feb 27, 2025 Planned sale John T. Henderson (Chairman of our Board of Directors) adopted a 10b5-1 trading planreported in the 10-K, up to 31,872 shares, runs to May 20, 2025
- Feb 27, 2025 Planned sale Fady Malik (Executive Vice President, Research & Development) adopted a 10b5-1 trading planreported in the 10-K, up to 49,000 shares, runs to Dec 19, 2025
- Feb 27, 2025 Planned sale Robert Harrington (Director) adopted a 10b5-1 trading planreported in the 10-K, up to 1,350 shares, runs to Nov 1, 2025
- Feb 27, 2025 Planned sale Muna Bhanji (Director) adopted a 10b5-1 trading planreported in the 10-K, up to 1,454 shares, runs to Jun 30, 2025
- Feb 27, 2025 Planned sale Andrew Callos (Executive Vice President, Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 61,725 shares, runs to Mar 5, 2026
- Feb 27, 2025 Planned sale Robert I. Blum (President & Chief Executive Officer) ended a 10b5-1 trading planreported in the 10-K, up to 135,000 shares, runs to Nov 14, 2025
- Feb 27, 2025 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · Preferred Stock Debt Securities Warrants From time to time, Cytokinetics Incorporated or selling securityholders may offer and sell any combination of the securities described in this prospectus, either individually or in combination with other securities in one or more offerings.
- Feb 27, 2025 8-K Quarterly results8-K item 2.02
- Feb 27, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 11, 2025 8-K Director or officer change8-K item 5.02
- Dec 16, 2024 8-K Director or officer change8-K item 5.02
- Nov 19, 2024 8-K Material agreement signed8-K item 1.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 12, 2026 | 4 | Insider trade |
| Nov 9, 2026 | 144 | Notice of planned insider sale |
| Nov 4, 2026 | 10-Q | Quarterly report |
| Nov 4, 2026 | 8-K | Quarterly results |
| Nov 3, 2026 | 4 | Insider trade |
| Nov 2, 2026 | 4 | Insider trade |
| Oct 20, 2026 | 144 | Notice of planned insider sale |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 20, 2026 | 4 | Insider trade |
| Oct 13, 2026 | 144 | Notice of planned insider sale |
| Oct 13, 2026 | 4 | Insider trade |
| Oct 6, 2026 | 4 | Insider trade |
| Sep 28, 2026 | 4 | Insider trade |
| Sep 22, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 144 | Notice of planned insider sale |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 15, 2026 | 4 | Insider trade |
| Sep 11, 2026 | 144 | Notice of planned insider sale |
| Sep 11, 2026 | 4 | Insider trade |
| Sep 8, 2026 | 4 | Insider trade |
| Sep 1, 2026 | 144 | Notice of planned insider sale |
| Sep 1, 2026 | 4 | Insider trade |
| Aug 31, 2026 | 4 | Insider trade |
| Aug 31, 2026 | 4 | Insider trade |
| Aug 28, 2026 | 8-K | Other events |
| Aug 18, 2026 | 4 | Insider trade |
| Aug 13, 2026 | 8-K | Other events |
| Aug 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 10, 2026 | 4 | Insider trade |
| Aug 6, 2026 | 10-Q | Quarterly report |
| Aug 6, 2026 | 8-K | Quarterly results |
| Jul 30, 2026 | 144 | Notice of planned insider sale |
| Jul 30, 2026 | 4 | Insider trade |
| Jul 27, 2026 | 4 | Insider trade |
| Jul 23, 2026 | 4 | Insider trade |
| Jul 16, 2026 | 4 | Insider trade |
| Jul 16, 2026 | 4 | Insider trade |
| Jul 16, 2026 | 4 | Insider trade |
| Jul 16, 2026 | 4 | Insider trade |
| Jul 16, 2026 | 4 | Insider trade |
| Jul 16, 2026 | 4 | Insider trade |
| Jul 14, 2026 | 4 | Insider trade |
| Jul 8, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 7, 2026 | 144 | Notice of planned insider sale |
| Jul 7, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 1, 2026 | 144 | Notice of planned insider sale |
| Jun 29, 2026 | 144 | Notice of planned insider sale |
| Jun 29, 2026 | 4 | Insider trade |
| Jun 29, 2026 | 4 | Insider trade |
| Jun 26, 2026 | 144 | Notice of planned insider sale |
| Jun 24, 2026 | 144 | Notice of planned insider sale |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 144 | Notice of planned insider sale |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| Jun 1, 2026 | 4 | Insider trade |
| May 28, 2026 | 4 | Insider trade |
| May 27, 2026 | S-8 | Shares registered for employee plans |
| May 27, 2026 | 8-K | Shareholder vote results |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 27, 2026 | 4 | Insider trade |
| May 20, 2026 | 4 | Insider trade |
| May 14, 2026 | 4 | Insider trade |
| May 8, 2026 | 8-K | Other events |
| May 7, 2026 | 424B5 | Prospectus |
| May 6, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 5, 2026 | 144 | Notice of planned insider sale |
| May 5, 2026 | 144 | Notice of planned insider sale |
| May 5, 2026 | 144 | Notice of planned insider sale |
| May 5, 2026 | 424B5 | Prospectus |
| May 5, 2026 | 8-K | Other events |
| May 5, 2026 | 10-Q | Quarterly report |
| May 5, 2026 | 8-K | Quarterly results |
| May 5, 2026 | 4 | Insider trade |
| May 5, 2026 | 4 | Insider trade |
| May 5, 2026 | 4 | Insider trade |
| May 5, 2026 | 4 | Insider trade |
| May 5, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| Apr 30, 2026 | 4 | Insider trade |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | 4 | Insider trade |
| Apr 21, 2026 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CYTK/export.csv") into a cell.